Trade Summary

3 days ago, Fordyce Marshall, serving as PRESIDENT AND CEO at Vera Therapeutics, Inc. (VERA), sold 46,250 shares at $42.30 per share, for a total transaction value of $1,956,187.12. Following this transaction, Fordyce Marshall now holds 151,994 shares of VERA.

This sale represents a 23.33% decrease in Fordyce Marshall's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, July 7, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 9, 2026 at 4:45 PM ET, 2 days after the trade was made.

Vera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.